Al Kraus - Net Worth and Insider Trading

Al Kraus Net Worth

The estimated net worth of Al Kraus is at least $120,943 dollars as of 2024-11-11. Al Kraus is the Director of CytoSorbents Corp and owns about 130,046 shares of CytoSorbents Corp (CTSO) stock worth over $120,943. Details can be seen in Al Kraus's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Al Kraus has not made any transactions after 2022-05-06 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Al Kraus

To

Al Kraus Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Al Kraus owns 1 companies in total, including CytoSorbents Corp (CTSO) .

Click here to see the complete history of Al Kraus’s form 4 insider trades.

Insider Ownership Summary of Al Kraus

Ticker Comapny Transaction Date Type of Owner
CTSO CytoSorbents Corp 2022-05-06 director

Al Kraus Latest Holdings Summary

Al Kraus currently owns a total of 1 stock. Al Kraus owns 130,046 shares of CytoSorbents Corp (CTSO) as of May 6, 2022, with a value of $120,943.

Latest Holdings of Al Kraus

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
CTSO CytoSorbents Corp 2022-05-06 130,046 0.93 120,943

Holding Weightings of Al Kraus


Al Kraus Form 4 Trading Tracker

According to the SEC Form 4 filings, Al Kraus has made a total of 3 transactions in CytoSorbents Corp (CTSO) over the past 5 years, including 1 buys and 2 sells. The most-recent trade in CytoSorbents Corp is the acquisition of 5,000 shares on May 6, 2022, which cost Al Kraus around $9,800.

Insider Trading History of Al Kraus

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Al Kraus Trading Performance

GuruFocus tracks the stock performance after each of Al Kraus's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Al Kraus is 12.9%. GuruFocus also compares Al Kraus's trading performance to market benchmark return within the same time period. The performance of stocks bought by Al Kraus within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Al Kraus's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Al Kraus

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
1 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 2.15 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 2.2 LIMIT LIMIT LIMIT LIMIT LIMIT

Al Kraus Ownership Network

Ownership Network List of Al Kraus

No Data

Ownership Network Relation of Al Kraus

Insider Network Chart

Al Kraus Owned Company Details

What does CytoSorbents Corp do?

Who are the key executives at CytoSorbents Corp?

Al Kraus is the director of CytoSorbents Corp. Other key executives at CytoSorbents Corp include Chief Financial Officer Kathleen P. Bloch , Chief Operating Officer Vincent Capponi , and director & President and CEO Phillip P. Chan .

CytoSorbents Corp (CTSO) Insider Trades Summary

Over the past 18 months, Al Kraus made no insider transaction in CytoSorbents Corp (CTSO). Other recent insider transactions involving CytoSorbents Corp (CTSO) include a net purchase of 40,894 shares made by Kathleen P. Bloch , a net purchase of 40,594 shares made by Michael G. Bator , and a net purchase of 75,188 shares made by Phillip P. Chan .

In summary, during the past 3 months, insiders sold 0 shares of CytoSorbents Corp (CTSO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of CytoSorbents Corp (CTSO) were sold and 235,625 shares were bought by its insiders, resulting in a net purchase of 235,625 shares.

CytoSorbents Corp (CTSO)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

CytoSorbents Corp Insider Transactions

No Available Data

Al Kraus Mailing Address

Above is the net worth, insider trading, and ownership report for Al Kraus. You might contact Al Kraus via mailing address: Medasorb Technologies, 7 Deer Park Drive, Suite K, Monmouth Junction Nj 08852.